View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Senior Member, Vice Chair
Malignant Hematology
Section Head
Leukemia and MDS
H. Lee Moffitt Cancer Center & Research Institute
Professor
Department of Oncologic Sciences
University of South Florida
Tampa, Florida
Associate Scientific Director
Scientific Director
Scientific Director
Senior Clinical Editor
Associate Director, Scientific Services
Senior Director, Educational Strategy
Director, CME Program Development
Director, Program Development and Educational Impact
Adult Oncology Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, Indiana
This program is intended for physicians, oncology nurses, pharmacists, and other healthcare providers who care for patients with MDS.
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.
CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-008-H01-P.
Type of Activity: Knowledge
Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 15, 2021, through January 14, 2022:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate.
After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page.
Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Sara Tinsley, PhD, APRN, AOCN
Released: November 29, 2021
Amer M. Zeidan, MBBS, discusses novel and investigational therapies for treating patients with myelodysplastic syndromes (MDS) in this commentary from Clinical Care Options (CCO)
Amer Zeidan, MBBS
Released: November 22, 2021
A downloadable slideset on the care of older patients with myelodysplastic syndromes from Clinical Care Options (CCO).
Jamile Shammo, MD, FASCP, FACP
Rami S. Komrokji, MD
Released: October 21, 2021
Download this expert-authored resource on current treatment algorithms for MDS from Clinical Care Options (CCO)
Jamile Shammo, MD, FASCP, FACP
Released: October 18, 2021
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.